BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
Diabetes mellitus
,
Heart
,
Metabolism of nitric oxide
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
a 192
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Simpson-Golabi-Behmel syndrome (SGBS) preadipocytes overexpressing a miR-192 mimic
HCT-116 colon cancer cells overexpressing p53-regulated microRNAs miR-192 and miR-215
CD8+ memory precursor effector (MPEC) cells of mice immunized with dendritic cells and TLR4 ligands
Hepatocytes isolated from rats and treated with 29 ToxCast chemicals in a dose-dependent manner
Psoriatic lesional/non-lesional skin of ustekinumab or etanercept-treated responders/non-responders
Explore Curated Studies Results
Literature
Most Relevant Literature
Determination of transit dose profile for a (192)Ir HDR source.
Overview of the National Ignition Facility.
Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brac…
Determination of absorbed dose to water around a clinical HDR (192)Ir source using LiF:Mg,Ti TLDs de…
Prevalence and predictors of idiopathic asymmetry in infants born preterm.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of ICP-192 in Patients With Advanced Solid Tumors
Clinical Study of ICP-192 in Solid Tumors Patients
Determining Serum and Urinary Levels of miRNA 192 and miRNA 25 in Patients With and Without Type 2 D…
An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate At…
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholang…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ